摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-苄基-2,5-二甲基-1H-吡咯-3-甲醛 | 56018-32-7

中文名称
1-苄基-2,5-二甲基-1H-吡咯-3-甲醛
中文别名
——
英文名称
1-benzyl-2,5-dimethyl-3-formylpyrrole
英文别名
1-benzyl-2,5-dimethyl-1H-pyrrole-3-carbaldehyde;1-Benzyl-2,5-dimethyl-pyrrol-3-carbaldehyd;1-benzyl-2,5-dimethyl-pyrrole-3-carbaldehyde;1-benzyl-2,5-dimethylpyrrole-3-carbaldehyde
1-苄基-2,5-二甲基-1H-吡咯-3-甲醛化学式
CAS
56018-32-7
化学式
C14H15NO
mdl
MFCD05998731
分子量
213.279
InChiKey
DRUVRRDEWCSBFW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    22
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 海关编码:
    2933990090

SDS

SDS:08f696acdacc5242debc20eb5781fed9
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-甲基-2-甲基亚氨基-1,3-噻唑烷-4-酮1-苄基-2,5-二甲基-1H-吡咯-3-甲醛哌啶 作用下, 以 乙醇 为溶剂, 反应 4.0h, 生成 5-[(1-Benzyl-2,5-dimethylpyrrol-3-yl)methylidene]-3-methyl-2-methylimino-1,3-thiazolidin-4-one
    参考文献:
    名称:
    Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype
    摘要:
    High affinity and selective S1P(4) receptor (S1P(4)-R) small molecule agonists may be important proof-of-principle tools used to clarify the receptor biological function and effects to assess the therapeutic potential of the S1P4-R in diverse disease areas including treatment of viral infections and thrombocytopenia. A high-throughput screening campaign of the Molecular Libraries-Small Molecule Repository was carried out by our laboratories and identified (2Z,5Z)-5-((1-(2-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-3-methyl-2-(methylimino) thiazolidin-4-one as a promising S1P(4)-R agonist hit distinct from literature S1P(4)-R modulators. Rational chemical modifications of the hit allowed the identification of a promising lead molecule with low nanomolar S1P(4)-R agonist activity and exquisite selectivity over the other S1P(1-3,5)-Rs family members. The lead molecule herein disclosed constitutes a valuable pharmacological tool to explore the effects of the S1P(4)-R signaling cascade and elucidate the molecular basis of the receptor function. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.09.049
  • 作为产物:
    参考文献:
    名称:
    5,10-亚甲基四氢-5-脱氮磷酸及其类似物:合成和生物活性。
    摘要:
    据报道,5,10-亚甲基四氢叶酸(1)的稳定,刚性类似物5,10-亚甲基-5-脱氮基氢氢叶酸(2)的合成可能是胸苷酸合酶的抑制剂。通过从2-氨基-6-肼基-4-氧代嘧啶(10)和二乙基N- [4-(3-甲酰基-1-吡咯基)苯甲酰基]-的amino16的Fisher-吲哚型环化obtained得到目标化合物。 L-谷氨酸(15),然后催化还原产物17。类似地,对适当的前体11和12进行Fisher-吲哚型环化的修饰得到非经典类似物3-氨基-7,8,9-三甲基-2H -吡咯并[3',4':4,5]吡啶并[2,3-d]嘧啶-1-一(4)和3-氨基-8-苄基-7,9-二甲基-2H-吡咯并[3' ,4':4,5]吡啶并[2,3-d]嘧啶-1-酮(5)。目标化合物2及其芳香族前体18 和非经典类似物4被评估为Manca人淋巴瘤细胞生长的抑制剂,也被评估为人二氢叶酸还原酶,人胸苷酸合酶,甘氨酰胺核糖核苷
    DOI:
    10.1021/jm00098a013
点击查看最新优质反应信息

文献信息

  • Novel indium-mediated deoxygenative α,α-diallylation of indole- and pyrrole-3-carboxaldehydes
    作者:Subodh Kumar、Vijay Kumar、Swapandeep Singh Chimni
    DOI:10.1016/s0040-4039(02)01973-1
    日期:2002.11
    1-Alkylindole-3-carboxaldehydes 1 and pyrrole-3-carboxaldehydes 2 on stirring with indium (2 equiv.) and allyl bromide (3 equiv.) in THF-H2O undergo deoxygenative diallylation at the carbonyl carbon to provide 3-[1,6-diene-4-yl]- indole 3 and pyrrole 4 derivatives. The formation of the normal 1,2-addition product in the case of 1d (R = COOEt) points towards the contribution of electronic factors due to the enamine double bond in the deoxygenation process. (C) 2002 Published by Elsevier Science Ltd.
  • Discovery and Structure–Activity Relationships of Pyrrolone Antimalarials
    作者:Dinakaran Murugesan、Alka Mital、Marcel Kaiser、David M. Shackleford、Julia Morizzi、Kasiram Katneni、Michael Campbell、Alan Hudson、Susan A. Charman、Clive Yeates、Ian H. Gilbert
    DOI:10.1021/jm400009c
    日期:2013.4.11
    In the pursuit of new antimalarial leads, a phenotypic screening of various commercially sourced compound libraries was undertaken by the World Health Organisation Programme for Research and Training in Tropical Diseases (WHO-TDR). We report here the detailed characterization of one of the hits from this process, TDR32750 (8a), which showed potent activity against Plasmodium falciparum K1 (EC50 similar to 9 nM), good selectivity (>2000-fold) compared to a mammalian cell line (L6), and significant activity against a rodent model of malaria when administered intraperitoneally. Structure-activity relationship studies have indicated ways in which the molecule could be optimized. This compound represents an exciting start point for a drug discovery program for the development of a novel antimalarial.
  • FRITZ H.; SCHENK S., J. LIEBIGS ANN. CHEM. <JLAC-BF>, 1975, NO 2, 255-265
    作者:FRITZ H.、 SCHENK S.
    DOI:——
    日期:——
  • Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype
    作者:Mariangela Urbano、Miguel Guerrero、Subash Velaparthi、Melissa Crisp、Peter Chase、Peter Hodder、Marie-Therese Schaeffer、Steven Brown、Hugh Rosen、Edward Roberts
    DOI:10.1016/j.bmcl.2011.09.049
    日期:2011.11
    High affinity and selective S1P(4) receptor (S1P(4)-R) small molecule agonists may be important proof-of-principle tools used to clarify the receptor biological function and effects to assess the therapeutic potential of the S1P4-R in diverse disease areas including treatment of viral infections and thrombocytopenia. A high-throughput screening campaign of the Molecular Libraries-Small Molecule Repository was carried out by our laboratories and identified (2Z,5Z)-5-((1-(2-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-3-methyl-2-(methylimino) thiazolidin-4-one as a promising S1P(4)-R agonist hit distinct from literature S1P(4)-R modulators. Rational chemical modifications of the hit allowed the identification of a promising lead molecule with low nanomolar S1P(4)-R agonist activity and exquisite selectivity over the other S1P(1-3,5)-Rs family members. The lead molecule herein disclosed constitutes a valuable pharmacological tool to explore the effects of the S1P(4)-R signaling cascade and elucidate the molecular basis of the receptor function. (C) 2011 Elsevier Ltd. All rights reserved.
  • 5,10-Methylenetetrahydro-5-deazafolic acid and analogs: synthesis and biological activities
    作者:Aleem Gangjee、Jasmin Patel、Roy L. Kisliuk、Yvette Gaumont
    DOI:10.1021/jm00098a013
    日期:1992.10
    precursors 11 and 12 afforded the nonclassical analogues 3-amino-7,8,9-trimethyl-2H-pyrrolo[3',4':4,5]pyrido[2,3-d]pyrimidin-1- one (4) and 3-amino-8-benzyl-7,9-dimethyl-2H-pyrrolo[3',4':4,5]pyrido [2,3-d]pyrimidin-1-one (5), respectively. The target compound 2, its aromatic precursor 18, and the nonclassical analogue 4 were evaluated as inhibitors of the growth of Manca human lymphoma cells and also as inhibitors
    据报道,5,10-亚甲基四氢叶酸(1)的稳定,刚性类似物5,10-亚甲基-5-脱氮基氢氢叶酸(2)的合成可能是胸苷酸合酶的抑制剂。通过从2-氨基-6-肼基-4-氧代嘧啶(10)和二乙基N- [4-(3-甲酰基-1-吡咯基)苯甲酰基]-的amino16的Fisher-吲哚型环化obtained得到目标化合物。 L-谷氨酸(15),然后催化还原产物17。类似地,对适当的前体11和12进行Fisher-吲哚型环化的修饰得到非经典类似物3-氨基-7,8,9-三甲基-2H -吡咯并[3',4':4,5]吡啶并[2,3-d]嘧啶-1-一(4)和3-氨基-8-苄基-7,9-二甲基-2H-吡咯并[3' ,4':4,5]吡啶并[2,3-d]嘧啶-1-酮(5)。目标化合物2及其芳香族前体18 和非经典类似物4被评估为Manca人淋巴瘤细胞生长的抑制剂,也被评估为人二氢叶酸还原酶,人胸苷酸合酶,甘氨酰胺核糖核苷
查看更多